JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Ending Cash Position : ฿34.30 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Ending Cash Position?

JSP Pharmaceutical Manufacturing (Thailand) PCL's Ending Cash Position for the quarter that ended in Mar. 2024 was ฿34.30 Mil.

JSP Pharmaceutical Manufacturing (Thailand) PCL's quarterly Ending Cash Position declined from Sep. 2023 (฿37.06 Mil) to Dec. 2023 (฿20.65 Mil) but then increased from Dec. 2023 (฿20.65 Mil) to Mar. 2024 (฿34.30 Mil).

JSP Pharmaceutical Manufacturing (Thailand) PCL's annual Ending Cash Position declined from Dec. 2021 (฿623.91 Mil) to Dec. 2022 (฿100.20 Mil) and declined from Dec. 2022 (฿100.20 Mil) to Dec. 2023 (฿20.65 Mil).

JSP Pharmaceutical Manufacturing (Thailand) PCL Ending Cash Position Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL Ending Cash Position Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

0.14

0.49

623.91

100.20

20.65

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial										121.54	60.08	37.06	20.65	34.30

JSP Pharmaceutical Manufacturing (Thailand) PCL Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

JSP Pharmaceutical Manufacturing (Thailand) PCL's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	100.196	+	-79.542
	=	20.65

JSP Pharmaceutical Manufacturing (Thailand) PCL's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	20.654	+	13.645
	=	34.30

JSP Pharmaceutical Manufacturing (Thailand) PCL Ending Cash Position Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120

Website

https://www.jsppharma.com

JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Headlines

No Headlines